Check targeted lymph node surgery for early breast cancer
Part of Cancer, Skin clinical trials.
This study tests a more focused surgery approach to remove lymph nodes in the armpit for people with early breast cancer that has been found in 1–2 axillary lymph nodes. It may help guide more precise treatment while checking how well this approach works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have early invasive breast cancer in the breast (T1 or T2 type), and it can be any hormone or HER2 subtype.
- On exam, your armpit lymph nodes feel normal (N0) but ultrasound shows up to two suspicious nodes, and biopsy confirms cancer in the armpit node(s).
- Your overall health/mobility score must be less than 2 (you can do daily activities with limited trouble).
- You must sign a study consent form after understanding it.
- You should not have had prior surgery in the same armpit area, prior axillary (armpit) radiation, distant spread (metastases), or chemotherapy before surgery (neoadjuvant therapy).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is checking a new way to find and remove lymph nodes that may contain cancer when there are only one or two affected nodes. The goal is to see if this method works well and to help guide further treatment.
This trial studies an additional treatment given after chemotherapy for locally advanced breast cancer that has spread to specific underarm lymph nodes. It may help some people reduce cancer returning, especially when tumors match certain growth and spread features.
This trial studies whether you can safely avoid a lymph node biopsy in the armpit for early breast cancer when scans and exams look negative. It may reduce surgery-related side effects while still keeping cancer care on track.
This study looks at the safest and most useful way to remove and check breast-cancer lymph nodes in the armpit after you finish chemotherapy given before surgery. It may help you avoid unnecessary surgery while still getting accurate information about how well the treatment worked.
This trial compares two ways to treat the underarm lymph nodes in people whose sentinel lymph node still shows limited cancer after chemotherapy and hormone treatment. It may help find which approach controls cancer better with fewer side effects.
This trial is for women age 45 and older with early ER-positive breast cancer that has spread to the lymph nodes under the arm. It tests a surgery approach where the main tumor and only a few key lymph nodes (rather than many) are removed.
Hear when a new Breast Cancer Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.